Soleno Therapeutics, Inc. Share Price
Stocks
SLNO
US8342033094
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 53.01 USD | +0.04% |
|
-.--% | +14.49% |
| 20/05 | Soleno Therapeutics, Inc.(NasdaqGM:) dropped from Russell Small Cap Comp Growth Benchmark | CI |
| 20/05 | Soleno Therapeutics, Inc.(NasdaqGM:) dropped from Russell 3000E Growth Benchmark | CI |
| Market Cap | 276.29Cr 238.63Cr 219.9Cr 205.84Cr 385.75Cr 26TCr 391.72Cr 2.6TCr 1.01TCr 13TCr 1.04TCr 1.01TCr 44TCr | P/E Ratio 2024 |
-10.3x | P/E Ratio 2025 | 119x |
|---|---|---|---|---|---|
| Enterprise Value | 230.94Cr 199.46Cr 183.8Cr 172.05Cr 322.43Cr 22TCr 327.42Cr 2.17TCr 846.17Cr 11TCr 866.7Cr 848.25Cr 37TCr | EV / Sales 2024 |
-
| EV / Sales 2025 | 1,06,78,497x |
| Free-Float |
98.88% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Soleno Therapeutics, Inc.
| 1 day | +0.04% | ||
| 1 month | +0.04% | ||
| 3 months | +57.04% | ||
| 6 months | +1.94% | ||
| Current year | +14.49% |
| Current year | 29.43 |  | 53.01 |
| 1 year | 29.43 | | 90.32 |
| 3 years | 3.69 | | 90.32 |
| 5 years | 0.85 | | 90.32 |
| 10 years | 0.85 | | 99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Darin Lippoldt
PSD | President | 61 | 15/05/2026 |
| Treasurer | 47 | 15/05/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Darin Lippoldt
BRD | Director/Board Member | 61 | 15/05/2026 |
| Director/Board Member | 47 | 15/05/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 18/05 | Issuer sale | Chief Development Officer | -97,192 | 0.1883% | ||
| 18/05 | Issuer sale | Chief Commercial Officer | -2,17,507 | 0.4213% | ||
| 18/05 | Issuer sale | Director | -16,991 | 0.0329% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.04% | -.--% | -33.03% | +851.71% | 276.29Cr | |
| -1.56% | +1.07% | +59.68% | +113.80% | 5.64TCr | |
| +2.72% | +3.26% | +46.05% | +47.37% | 4.45TCr | |
| +1.12% | +2.79% | -15.04% | -18.40% | 2.29TCr | |
| +1.17% | +3.85% | -0.89% | +407.26% | 2.12TCr | |
| -0.51% | +1.78% | +16.68% | -34.63% | 1.64TCr | |
| +0.12% | +0.59% | +9.90% | -38.27% | 1.54TCr | |
| -0.69% | +0.82% | +27.75% | +182.91% | 1.34TCr | |
| +0.96% | +9.74% | +17.55% | - | 1.24TCr | |
| +1.61% | +1.28% | +95.75% | +206.59% | 1.12TCr | |
| Average | +0.40% | +1.89% | +22.44% | +190.93% | 2.16TCr | |
| Weighted average by Cap. | +0.35% | +2.34% | +32.54% | +111.15% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 190.4 164.45 151.54 141.85 265.84 18.1T 269.96 1.79T 697.66 8.81T 714.59 699.38 30.5T |
| Net income | -18Cr -15Cr -14Cr -13Cr -25Cr -1.67TCr -25Cr -165.26Cr -64Cr -813.56Cr -66Cr -65Cr -2.82TCr | 2.09Cr 1.8Cr 1.66Cr 1.56Cr 2.92Cr 198.56Cr 2.96Cr 20Cr 7.65Cr 97Cr 7.84Cr 7.67Cr 334.64Cr |
| Net Debt | -27Cr -23Cr -21Cr -20Cr -37Cr -2.53TCr -38Cr -249.81Cr -97Cr -1.23TCr -100Cr -98Cr -4.26TCr | -45Cr -39Cr -36Cr -34Cr -63Cr -4.31TCr -64Cr -426.22Cr -166.18Cr -2.1TCr -170.21Cr -166.59Cr -7.27TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- SLNO Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition